Lipid-lowering properties of protein-rich mucuna product

被引:0
|
作者
Ngatchic J.T.M. [1 ]
Njintang N.Y. [2 ]
Bernard C. [3 ]
Oben J. [4 ]
Mbofung C.M. [1 ]
机构
[1] Department of Food Science and Nutrition, National School of Agro-industrial Science, P.O. Box 455, Ngaoundere
[2] Department of Biological Sciences, Faculty of Sciences, University of Ngaoundere, P.O. Box 454, Ngaoundere
[3] Industrial school of Biology, EBInnov Laboratory, 32 boulevard du port, 95094 Cergy, Pontoise Cedex
[4] Department of Biochemistry, Faculty of Sciences, University of Yaounde, P.O. Box 812, Yaounde
关键词
Cholesterol; Oxidative stress; Protein-rich mucuna product; Steatosis; Triglycerides;
D O I
10.1186/s41110-016-0003-0
中图分类号
学科分类号
摘要
Background: The objective of this study is to evaluate the effect of protein-rich mucuna product (PRMP) on lipid parameters of hyperlipidemic rats. Methods: Hyperlipidemia was induced in male rats for 3 weeks through high-fat diet. After induction, 30 hyperlipidemic rats were divided into five groups of six rats: control group (CG) received casein and four groups received PRMP as protein source at different proportions: 8.2, 16.4, 24.6, and 32.8 % corresponding, respectively, to 25, 50, 75, and 100 % substitution of casein in the diet for 3 weeks. Lipid and oxidative stress parameters of rats were assessed. Results: There were no significant differences in food intake and body weight loss among the experimental groups. The concentrations of the serum low-density lipoprotein cholesterol, total cholesterol, and triglycerides were lower in groups fed on PRMP 50, 75, and 100 % than in the CG group (p < 0.05). Histological analysis of the liver revealed that animals fed on PRMP diets presented a lower level of steatosis than the CG group. The most significant reduction of lipid parameters was obtained when PRMP was used as unique source of protein (PRMP 100 %). PRMP also influenced oxidative stress parameters as evidenced by a decrease in malondialdehyde and an increase in catalase and superoxide dismutase. Conclusions: These findings demonstrated that PRMP exerts hypolipidemic effect; it has a metabolic effect on endogenous cholesterol metabolism and a protector effect on the development of hepatic steatosis. Our results also suggest that PRMP could manage metabolic diseases associated with oxidative stress. © 2016, The Author(s).
引用
收藏
相关论文
共 50 条
  • [21] Lipid-lowering drugs and homocysteine - A comparison between statins and other lipid-lowering drugs
    Jankowski, P
    Kawecka-Jaszcz, K
    ATHEROSCLEROSIS, 2004, 172 (01) : 191 - 194
  • [22] Supplementation of Sulfur-Containing Amino Acids or Essential Amino Acids Does Not Reverse the Hepatic Lipid-Lowering Effect of a Protein-Rich Insect Meal in Obese Zucker Rats
    Meyer, Sandra
    Schaefer, Lea
    Roehrig, Julia
    Maheshwari, Garima
    Most, Erika
    Zorn, Holger
    Ringseis, Robert
    Eder, Klaus
    Gessner, Denise K.
    NUTRIENTS, 2020, 12 (04)
  • [23] LIPID-LOWERING DIETARY ADVICE
    ANGELICO, F
    VOLPE, R
    BRITISH MEDICAL JOURNAL, 1995, 310 (6995): : 1669 - 1669
  • [24] Pharmacoeconomics of lipid-lowering drugs
    Dean G. Smith
    Current Atherosclerosis Reports, 2003, 5 (1) : 67 - 72
  • [25] LIPID-LOWERING THERAPY IN PERSPECTIVE
    THOMPSON, GR
    BRITISH JOURNAL OF CLINICAL PRACTICE, 1988, 42 (02): : 61 - 64
  • [26] LIPID-LOWERING EFFECTS OF PROCETOFENE
    AFSCHRIFT, M
    METS, T
    VERDONK, G
    LANCET, 1977, 2 (8032): : 311 - 311
  • [27] Lipid-lowering therapies in development
    Wierzbicki, AS
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (11) : 1405 - 1418
  • [28] Lipid-lowering Therapies in Myositis
    Marisa C. Mizus
    Eleni Tiniakou
    Current Rheumatology Reports, 2020, 22
  • [29] Choice of lipid-lowering drugs
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1998, 40 (1042): : 117 - 122
  • [30] Lipid-lowering drugs and cataract
    Bezin, J.
    Mansiaux, Y.
    Pariente, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 6 - 6